Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: August-29-08
Credit Expiration Date: August-29-09

Faculty

Brooks D. Cash, MD,FACP, FACG, CDR, MC, USN
Associate Professor of Medicine
National Naval Medical Center
Bethesda, MD

Karen E. Hall, MD, PhD Clinical Associate Professor
Unversity of Michigan Ann Arbor, MI

P. Jay Pasricha, MD
Professor of Medicine
Stanford University School of Medicine Stanford, CA

Eamonn M.M. Quigley, MD, FRCP, FACP, FACG, FRCPI
Professor of Medicine and Human Physiology,
National University of Ireland,
Ireland, Cork

Fergus Shanahan, MD, FRCPI, FRCP(UK), FRCP(C), FACP
Professor and Chair, Department of Medicine and Director, Biosciences Institute
University College Cork
Cork, Ireland


Lin Chang, MD
Professor of Medicine
UCLA School of Medicine
Los Angeles, CA

John F. Johanson MD, MSc, FACP, FACG
Clinical Associate Professor
University of Illinois
Rockford, IL

Brian E. Lacy, MD,PhD
Director, Gastrointestinal Motility
Dartmouth-Hitchcock Medical Center
Lebanon, NH

Satish S. C. Rao, MD,PhD, FRCP (LON)
Professor of Medicine
University of Iowa Hospitals & Clinics
Iowa City, IA

Lawrence R. Schiller, MD, FACP, FACG
Program Director Gastroenterology Fellowship
Baylor University Medical Center
Dallas, TX

Brennan M.R. Spiegel, MD, MSHS
Assistant Professor of Medicine
University of California
Los Angeles, CA

William D. Chey, MD, AGAF, FACG, FACP
Professor of Medicine
University of Michigan Health System
Ann Arbor, MI

Richard J. Saad, MD
Assistant Professor of Medicine
University of Michigan Health System
Ann Arbor, MI

Credit Hours

4.0 (4 hot topics, at 30 minutes each)
4.0 (8 modules at 30 minutes each)

Medium

Link - Online

Program Description

The Information Center is a CME/CE-certified, on-line activity for physicians, physician assistants and nurse practitioners, providing an exciting, up-to-date web portal focused on IBS-C and CC. Authored by leading experts in the field of constipation-related disorders, this on-line e-learning syllabus program provides in-depth, evidence-based Core Modules addressing key topics in IBS-C and CC. Also provides a series of Hot Topic Updates, adding important supplementary information to the Core Modules.

Suitable for individual or group learning, with many downloadable components, this will be an invaluable resource to help ensure you are aware of all the latest developments in the field of constipation-related disorders. The modular approach enables you to enter the activity at points where you feel you have the most pressing educational need. This will facilitate the greater understanding of these common disorders and will be associated with a subsequent improvement in care offered to patients who suffer from these debilitating conditions.

CME/CE credits are available on a modular basis and are not dependant on completion of all activities available on the e-learning center.

Program Developer/Facilitator

.

Target Audience

Physicians, physician assistants and nurse practitioners.

Learning Objectives

At the conclusion of this entire activity, participants should be able to:

  1. Describe the epidemiology, demographics and risk factors associated with CC and IBS-C.
  2. Relate the pathophysiology of these conditions to the presentation of the patient’s symptoms and to describe the potential for overlap in the etiology of these conditions.
  3. Develop a confident in-office diagnosis of CC/IBS-C, on the basis of the patient’s symptom complex.
  4. Identify alarm features and appreciate when to refer patients for specialist evaluation.
  5. Determine what hospital-based tests offer the greatest diagnostic yield.
  6. Empathize with patients’ concerns about their symptoms and recognize what is likely to bother patients most about their condition.
  7. Evaluate the evidence for current treatments and describe the current best practice in the management of CC and IBS-C (both in typical patients and in subgroups of patients).
  8. Learning objectives: Hot Topics update 1

    At the conclusion of this entire activity, participants should be able to:
    1. Review and interpret existing data linking visceral hypersensitivity to the pathophysiology of IBS
    2. Distinguish IBS-C from other overlapping GI disorders including CC; identify and select appropriate methods for diagnosing constipation and IBS; evaluate when these tests should be implemented
    3. Define the mechanisms of action of probiotics as they apply to IBS; evaluate the evidence for probiotic treatment of IBS

    4. Describe the pathophysiology of the aging process in the lower gastrointestinal tract and recognize the impact this has on patients; evaluate available therapies for constipation as they relate to this patient population
  9. Learning objectives: Hot Topics update 2
    At the conclusion of this entire activity, participants should be able to:
    1. Evaluate the pharmacokinetics, pathophysiological rational and efficacy of novel therapeutic options as they relate to the treatment of IBS-C
    2. Determine how changes in GI motility may relate to symptoms of lower GI tract disorders
    3. Describe the mechanisms/role of intestinal fluid balance and state how this can influence GI transit and symptoms
    4. Evaluate the structure, function, and pharmacokinetics of novel therapeutic options as they relate to the treatment of CC

Disclosures

In direct response to the September 2004 Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, CME Consultants issued a conflict of interest policy dated January 2, 2005. The policy states that the disclosure of potential financial conflicts of interest within the last 12 months must be made and resolved prior to date of the CME/CE activity where commercial support grants are to be used to fund the activity. The following conflicts have been managed and resolved through CME Consultants’ Independent Review Committee. Our intent is to assist learners in assessing the potential for bias in information that is presented during the CME/CE activity.

The Faculty are also aware it is their responsibility to inform the audience if discussion of any non FDA approved uses of pharmaceutical, medical equipment, prostheses, etc. will be included in their presentation.

Brooks Cash, MD
Advisory Board – Takeda Pharmaceuticals
Speaker Bureau – Takeda Pharmaceuticals

Lin Chang, MD
Honorarium for Consultation – Takeda Pharmaceuticals

Karen Hall, MD
Nothing to disclose


John Johanson, MD
Advisory Board – Prometheus
Advisory Board – Salix
Advisory Board – Sucampo
Advisory Board – Takeda Pharmaceuticals
Honoraria – Speakers Bureau – Novartis
Honoraria – Speakers Bureau – Sucampo
Honoraria – Speakers Bureau – Takeda Pharmaceuticals

Brian Lacy, MD
Honoraria – Takeda Pharmaceuticals

P. Jay Pashricha, MD
Consultant/Advisory Board – Eurand
Consultant- Apollo Endosurgery
Consultant- GI Therapeutics
Consultant- Endopace
Consultant- Pentax
Consultant- GI Supply
Consultant- Procter and Gamble
Consultant- Dynogen
Consultant- Tranzyme
Consultant- Elixir
Consultant- Amulet
Consultant- Alteus


Eamonn Quigley, MD
Professor of Medicine and Human Physiology
National University of Ireland
Cork, Ireland
Owner of stock- Alimentary Health
Consultant- Alimentary Health
Consultant- AGI therapeutics
Consultant- Boehringer Ingelheim
Consultant- Procter and Gamble
Consultant- Norgine
Consultant- Sucampo
Consultant- Salix
Non-executive director (not an employee, no remuneration) - Alimentary Health

Satish Rao, MD
Advisory Board / Speaker – Takeda Pharmaceuticals
Advisory Board – Smart Pill Corporation
Advisory Board – Proctor & Gamble
Advisory Board – Forest Labs
Honoraria – Takeda Pharmaceuticals
Consultant Fee – Smart Pill
Consultant Fee – Proctor & Gamble
Consultant Fee – Forest Labs

Lawrence Schiller, MD
Advisory Board – Takeda Pharmaceuticals, Sucampo
Advisory Board – Abbott
Advisory Board - UCB
Advisory Board - McNeil
Advisory Board – Prometheus
Honoraria - Takeda, Sucampo
Honoraria - Abbott
Honoraria - UCB
Honoraria - McNeil
Honoraria - Prometheus
Honoraria - Procter & Gamble

Fergus Shanahan, MD
Shareholder- Alimentary Health Ltd

Brennan Spiegel, MD
Honoraria - TAP
Honoraria - AstraZeneca
Honoraria - Prometheus

William D. Chey, MD, AGAF, FACG, FACP
Advisory board / Honorarium - AGI
Advisory board / Honorarium - Albirei
Advisory board / Honorarium - Ironwood
Advisory board / Honorarium - Prometheus
Advisory board / Honorarium - Salix
Advisory board / Honorarium - Takeda
Honorarium - Axcan
Honorarium - Procter & Gamble
Advisory board / Honorarium - Santarus
Advisory board / Honorarium - Smart Pill

Richard J. Saad, MD
Nothing to disclose

The planners, managers and anyone in a position to control the content of CME activities are also required to report any conflicts of interest. The following conflicts have been managed and resolved through CME Consultants' Independent Review Committee.

Samantha Mattiucci, PharmD, CME Consultants
Nothing to disclose

Joyce M. Anderson, Project Director, CME Consultants
Nothing to disclose

Elena Urso, Associate Project Director, Strategic Consultants International
Nothing to disclose

Alison Howe, Managing Director, Strategic Consultants International Nothing to disclose

Credit Statements

Strategic Consultants International and CME Consultants jointly sponsor this CME/CE-certified activity.

ACCME: This Activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of CME Consultants and Strategic Consultants International (SCI). CME Consultants is accredited by the ACCME to provide continuing medical education for physicians.

Hot Topic Updates: CME Consultants designates this educational activity for a maximum of 4.0 AMA PRA Category I Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Hot Topics Update 1: CME Consultants designates this educational activity for a maximum of 2.0 AMA PRA Category I Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAPA – American Academy of Physician Assistants: This program has been reviewed and is approved for a maximum of 4.0 hours of AAPA Category 1 (Preapproved) CME credit by the Physician Assistant Review Panel. Physician Assistants should claim only those hours actually spent participating in the CME activity.

Hot Topics- AAPA – American Academy of Physician Assistants: This program has been reviewed and is approved for a maximum of 4.0 hours of AAPA Category 1 (Preapproved) CME credit by the Physician Assistant Review Panel. Physician Assistants should claim only those hours actually spent participating in the CME activity.

This program was planned in accordance with AAPA’s CME Standards for Enduring Programs and for Commercial Support of Enduring Programs.

AANP – American Academy of Nurse Practitioners: This program has been approved for 4.0 hours of continuing education by the American Academy of Nurse Practitioners. Program ID #0806295.

Hot Topics- AANP – American Academy of Nurse Practitioners: This program has been approved for 4.0 hours of continuing education by the American Academy of Nurse Practitioners. Program ID # 0901007

Commercial Support Statements

This activity was made possible through an educational grant provided by Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc.

Certificate Fee

$0.00

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS